Medtronic (MDT) Receives FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers
Tweet Send to a Friend
Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for a portfolio of quadripolar cardiac resynchronization ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
